Variable | Categorization | n analyzablea | % |
---|---|---|---|
Clinico-pathologic data: | |||
Age at diagnosis | |||
median 63.7 years (range 35–83 years) | |||
<50 years | 3 | 12 | |
= 50 years | 22 | 88 | |
Tumour stageb | |||
pT1 | 10 | 40 | |
pT2 | 10 | 40 | |
pT3 | 3 | 12 | |
pT4 | 2 | 8 | |
Lymph node statusb | |||
pN0 | 12 | 48 | |
pN1 | 1 | 4 | |
pN2 | 8 | 32 | |
pN3 | 4 | 16 | |
Histologic grade | |||
G1 | 0 | 0 | |
G2 | 10 | 40 | |
G3 | 15 | 60 | |
Histologic type | |||
ductal | 20 | 80 | |
lobular | 3 | 12 | |
mixed ductal/lobular | 1 | 4 | |
other | 1 | 4 | |
Immunohistochemistry (IHC): | |||
Estrogen receptor status | |||
negative (IRSc 0–2) | 5 | 20 | |
positive (IRS 3–12) | 20 | 80 | |
Progesterone receptor status | |||
negative (IRS 0–2) | 7 | 28 | |
positive (IRS 3–12) | 18 | 72 | |
HER2 IHC | |||
unknown | 2 | 8 | |
negative (0–1+) | 19 | 76 | |
positive (2+–3+) | 4 | 16 |